Becker's Hospital Review

October-2024-issue-of-beckers-hospital-review

Issue link: https://beckershealthcare.uberflip.com/i/1526981

Contents of this Issue

Navigation

Page 2 of 63

B I O S C I E N C E S , I N C . Congress did their part by expanding reimbursement for non-opioid postsurgical options. Now it's your turn: Learn more about the NOPAIN Act's mandate that Medicare provide ASP+6% reimbursement for qualifying non-opioid options in outpatient surgeries 1,2 Make a pact to support the Act, which goes into e ect January 1, 2025 References: 1. Congress.gov. One hundred seventeenth congress of the United States of America. Accessed June 12, 2024. https://www.congress.gov/117/ bills/hr2617/BILLS-117hr2617enr.pdf 2. CMS.gov. Medicare part B drug average sales price. Updated April 2, 2024. Accessed June 12, 2024. https://www.cms.gov/medicare/payment/ fee-for-service-providers/part-b-drugs/average-drug-sales-price ASP, average sales price; ASP+6 = reimbursement of 106% of the average sales price; NOPAIN Act, Non-Opioids Prevent Addiction in the Nation Act. © 2024 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. All rights reserved. PP-NP-1617 07/2024 VISIT NOPAINPact.com TO TAKE ACTION.

Articles in this issue

Links on this page

view archives of Becker's Hospital Review - October-2024-issue-of-beckers-hospital-review